Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT07498426

A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

This Phase III study is intended to evaluate the efficacy and safety of NIO752 in participants with Progressive Supranuclear Palsy (PSP). Eligible participants…

United States300 participantsStarted 2026-05-29

Treatment: NIO752, Placebo

All recent trials (2 shown)

CompletedPhase 1

NCT05187546

Test-retest Study With [18F]PI-2620 in PSP-RS and NDC

The overall goal of this protocol is to evaluate the imaging characteristics of \[18F\]PI-2620 using positron emission tomography (PET) in patients with progres…

Germany15 participantsStarted 2022-03-10

Treatment: [18F]-PI2620